SUPPORT HOTLINE (888) 901-2226
Donate Now

BRIEF TITLE: Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer

Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer


  • Org Study ID: STUDY00140348
  • Secondary ID:
  • NCT ID: NCT03063125
  • NCT Alias:
  • Sponsor: University of Kansas Medical Center - Other
  • Source: University of Kansas Medical Center

Brief Summary

The purpose of this study is to examine the relationship between testosterone level changes around the time of radical cystectomy.

Overal Status Start Date Phase Study Type
Recruiting March 31, 2017 N/A Observational

Primary Outcomes:

Primary Outcome 1 - Measure: Prevalence of hypogonadism

Primary Outcome 1 - Time Frame: 90 days post-RC surgery

Condition:

  • Bladder Cancer
  • Low Testosterone Levels

Eligibility

Criteria:
Inclusion Criteria:

- Diagnosis of bladder cancer

- Scheduled to undergo radical cystectomy

Exclusion Criteria:

- Evidence of advanced metastatic disease,

- Undergoing cystectomy for non-bladder primary malignancy or bladder cancer type other
than urothelial cell

- History of breast or prostate cancer

- Polycythemia, cardiovascular thromboembolism, untreated obstructive sleep apnea,
uncontrolled heart failure, or acute coronary event in the past six months
Show More

Gender: Male

Minimum Age: 18 Years

Maximum Age: N/A

Healthy Volunteers: No

Official Information

Name: Jeffrey Holzbeierlein, MD

Role: Principal Investigator

Affiliation: University of Kansas Medical Center

Overall Contact

Name: Katie Glavin

Phone: 913-588-8721

Email: kglavin@kumc.edu

Location

Facility Status Contact
University of Kansas Medical Center
Kansas City, Kansas 66160
United States
Recruiting